Install
PR Newswire’s news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
- 5,996articles · 30d
- 7+ hour agolatest article
- Aug 14, 2026earliest in window
- 92%with images
- 272avg words
- Economy, Business & Finance 2,817
- Finance & Business 2,246
- News 1,506
- Business & Industrial 789
- Science & Technology 653
- Health & Wellness 609
- Medical 563
- Arts, Culture, Entertainment & Media 529
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Helix Launches Whole Exome+® Sequencing for Patients with Rare and Unexplained Genetic Conditions
2+ day, 13+ hour ago (323+ words) Sep 10, 2026, 13:50 ET For patients with unexplained developmental delay, neurological conditions, and rare genetic disease, WES+ brings exome, mitochondrial, and chromosomal analysis together in a single order SAN MATEO, Calif., Sept. 10, 2026 /PRNewswire/ -- Helix, the leading enterprise genomics platform, today announced the…...
BioViva Secures U.S. Patent for hTERT and Follistatin-344 Gene Therapy Approach to Age-Related Disorders
2+ day, 18+ hour ago (426+ words) Sep 10, 2026, 09:13 ET The patent was issued by the United States Patent and Trademark Office on June 16, 2026, BioViva USA Inc. is the assignee. The patent represents an important addition to BioViva's intellectual-property portfolio focused on genetic approaches to age-related disorders. A…...
Ultima Genomics to Advance Pangenome-Aware Whole Genome Sequencing Analysis at Population Scale in Collaboration with NVIDIA, using Google's DeepVariant
3+ day, 19+ hour ago (458+ words) PR Newswire FREMONT, Calif., Sept. 9, 2026 /PRNewswire/ -- Ultima Genomics, a leader in ultra-high-throughput DNA sequencing, today announced a collaboration with NVIDIA to enable pangenome-aware whole genome sequencing (WGS) analysis at unprecedented scale. With the rapidly accelerating adoption of whole genome sequencing…...
American Lung Association Puts a Spotlight on Clinical Trials and How They Can Offer Hope to People Living With Lung Cancer
3+ day, 21+ hour ago (58+ words) Sep 09, 2026, 06:12 ET "Every person who participates in a clinical trial helps move research forward and brings us one step closer to better outcomes for all communities affected by lung cancer," said Wimmer. Support for the campaign was provided by Genentech…...
Stowers Institute partners with Google DeepMind and leading research institutions to help reveal the regulatory language of the human genome
4+ day, 8+ hour ago (664+ words) Sep 08, 2026, 19:27 ET The one-petabyte resource contains artificial intelligence-generated predictions for the molecular effects of more than 9 billion possible changes, creating what Google DeepMind describes as the most comprehensive catalogue of its kind. Stowers Institute Bioinformatics Scientist and Zeitlinger Lab member,…...
Groundbreaking ARUP Research Clarifies Clinical Value of Atypical Cell-Free DNA Screening Results
4+ day, 15+ hour ago (320+ words) Sep 08, 2026, 11:49 ET "No one has conducted a study as large as this on atypical findings," said Katie Rudd, PhD, FACMG, ARUP medical director of Cytogenetics and Genomic Microarray. She and her peers analyzed more than 10 years of data and more…...
IntelliGenome Appoints SIMED as Exclusive Distributor for CRISPR-TB™ in Peru and Ecuador
4+ day, 18+ hour ago (198+ words) Sep 08, 2026, 09:16 ET HOUSTON and QUITO, Ecuador, Sept. 8, 2026 /PRNewswire/ -- IntelliGenome, Inc. today announced the appointment of SIMED S.A. as its exclusive distributor for the CRISPR-TB™ Blood Test in Peru and Ecuador. IntelliGenome received DIGEMID registration approval for the CRISPR-TB Blood Test in…...
Global Genes Partners with Citizen Health to Power RARE-X
4+ day, 18+ hour ago (700+ words) PR Newswire RARE-X continues as an independent research platform, and expands its capabilities to support research through medical record data collection and medical management for families using Ari, Citizen Health's AI teammate SAN FRANCISCO and BOSTON, Sept. 8, 2026 /PRNewswire/ -- Global Genes…...
Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials
1+ week, 2+ day ago (706+ words) PR Newswire LOS ANGELES, Sept. 3, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today…...
New Johns Hopkins Study Identifies Pervasive RT-qPCR Artifact in CRISPR Knockdown Studies and How UltraMarathonRT® Solves It
1+ week, 3+ day ago (586+ words) PR Newswire Guide RNAs from RNA-targeting CRISPR systems remain bound to their target mRNA after total RNA preparations and suppress conventional reverse transcription. uMRT's strand-displacing reverse transcriptase restores accurate knockdown quantification. BRANFORD, Conn., Sept. 2, 2026 /PRNewswire/ -- RNAConnect, a life science company…...